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Abstract. Proximal tubular epithelial cells (PTEC) exhibit a
high sensitivity to undergo apoptosis in response to proinflam-
matory stimuli and immunosuppressors and participate in the
onset of several renal diseases. This study examined the ex-
pression of inducible nitric oxide (NO) synthase after challenge
of PTEC with bacterial cell wall molecules and inflammatory
cytokines and analyzed the pathways that lead to apoptosis in
these cells by measuring changes in the mitochondrial trans-
membrane potential and caspase activation. The data show that
the apoptotic effects of proinflammatory stimuli mainly were
due to the expression of inducible NO synthase. Cyclosporin A
and FK506 inhibited partially NO synthesis. However, both
NO and immunosuppressors induced apoptosis, probably
through a common mechanism that involved the irreversible
opening of the mitochondrial permeability transition pore. Ac-
tivation of caspases 3 and 7 was observed in cells treated with
high doses of NO and with moderate concentrations of immu-
nosuppressors. The conclusion is that the cooperation between
NO and immunosuppressors that induce apoptosis in PTEC
might contribute to the renal toxicity observed in the course of
immunosuppressive therapy.
Proximal tubular epithelial cells (PTEC) have been involved in
the pathophysiology of several renal diseases, as well as in
renal transplant rejection and drug-induced nephrotoxicity
(1,2). These studies indicate that tubular damage in various
renal diseases is dependent, at least in part, on caspase activa-
tion and induction of apoptosis, and the pathways regulating
this response are a subject of intense research (3–8). Previous
results showed a special sensitivity of these cells to undergo
apoptosis in the course of immunosuppression with cyclo-
sporin A (CsA) and FK506 (2,6,9). Indeed, both drugs are
nephrotoxic; each produces similar histologic patterns of injury
to renal tubules and preglomerular arterioles, and this toxicity
is a major cause of renal allograft dysfunction. The mecha-
nisms of CsA-induced nephrotoxicity are not fully understood,
but they seem to be associated with renal hypoxia and increases
in the synthesis of free radicals (10,11). In addition to this,
nitric oxide (NO) participates in CsA-dependent nephrotoxicity
(12,13). However, although the mechanism of NO-induced
apoptosis in these cells is well established (1,14–16), the
interaction between immunosuppressors and NO in terms of
potentiation of apoptosis still remains elusive.
The pathways that lead to apoptosis in response to NO
involve the release of mitochondrial mediators as deduced by the
prevention of apoptosis using caspase inhibitors acting down-
stream in the mitochondrial signaling pathway (17,18). Constitu-
tive expression of endothelial NO synthase (NOS-3) has been
identified in epithelial cells of the kidney, including those of the
proximal tubule, thick ascending limb, and inner medullar col-
lecting duct and in interstitial cells (19). Moreover, bacterial cell
wall products, such as lipopolysaccharide (LPS) and lipopeptides
(TPP), and proinflammatory cytokines, such as interleukin-1 (IL-
1b), interferon-g (IFN-g), and tumor necrosis factor-a (TNF-a),
are important mediators in the progression of acute renal failure,
which is a frequent complication of sepsis, and exert the cytotoxic
effects through the expression of the high-output NO synthase
NOS-2 (20). NO and its derived metabolite peroxynitrite
(ONOO–) participate in renal tubular cell injury, in the regulation
of renal hemodynamics and sodium tubular transport, and in the
cytotoxic mechanisms responsible for acute renal allograft rejec-
tion, where macrophages express high levels of NOS-2 (9). We
recently observed that the apoptosis caused by NO in peritoneal
macrophages was inhibited by treatment of the cells with CsA or
with FK506, mainly through the inhibition of the expression of
NOS-2 (21). In view of these results, we investigated whether
immunosuppressors and NO act on apoptotic signaling in PTEC,
because these cells have been described as extremely sensitive to
NO and CsA to induce apoptotic death. Our data show that
contrary to other cells, immunosuppressors and NO exert a syn-
ergistic action that induces apoptosis on PTEC, probably through
an increase of the release of mitochondrial apoptotic mediators as
reflected by the enhancement in the activity of caspases 3 and 7.
Materials and Methods
Chemicals
Chemical reagents were from Merck (Darmstadt, Germany), Roche
(Mannheim, Germany), and Sigma (St. Louis, MO) and were of the
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highest quality available. LPS from Escherichia coli, serotype 055:B5,
was from Sigma. The synthetic lipopeptide S-[2,3-bis(palmitoyl)-(2-RS)-
propyl]N-palmitoyl-(R)-Cys-Ser-Lys4 (TPP), murine recombinant IL-1b,
and murine recombinant TNF-a were from Roche. Materials and chem-
icals for electrophoresis were from Bio-Rad (Richmond, CA). Fluores-
cence probes were from Molecular Probes (Eugene, OR). Antibodies
were from Santa Cruz Biotechnology (Santa Cruz, CA). Culture media
were from BioWhittaker (Verviers, Belgium).
Preparation of Pig Proximal Tubule Cells
Kidneys from healthy isogeneic mini-pigs (Maryland strain) were
removed by surgery under sterile conditions. Animals were cared for
as outlined in the “Guide for the Care and Use of Laboratory Ani-
mals” (NIH publication). The kidney cortex (without medullar con-
tent) was sliced (2 mm slices) and incubated for 30 min at 37°C with
collagenase (0.6 mg/ml) in Ham’s-F12:Dulbecco’s modified Eagle’s
medium (vol:vol) (incubation medium). The digested tissue was cen-
trifuged at 100 3 g for 30 s, and the pellet was washed twice with
incubation medium. The cell pellet was resuspended in 45% Percoll
(10 ml of Percoll per gram of original tissue) and centrifuged at
20,000 3 g for 30 min. Proximal tubular cells banded in a well-
defined bottom layer that was characterized both biochemically and
morphologically following previous work (22). Cells (1 to 2 3 106)
were seeded in 6-cm dishes with incubation medium supplemented
with 2.5 mM glutamine, antibiotics, 10– 8 M hydrocortisone, and
2% of complement-free fetal calf serum. Cells were maintained for
2 d with a daily change of medium and used after the third day in
culture.
Measurement of Apoptosis
Apoptosis was determined by three independent criteria: the ap-
pearance of DNA fragmentation, the release of oligonucleosomes
Figure 1. Lipopolysaccharide (LPS), tris-palmitoyl-peptide (TPP), and interleukin-1b (IL-1b) increase nitric oxide (NO) synthesis in primary
cultures of proximal tubular epithelial cells. Cells (2 3 105) were stimulated with 1 mg/ml LPS, 5 mg/ml TPP, 20 ng/ml murine IL-1b, 100
ng/ml murine tumore necrosis factor-a (TNF-a), or combinations of these. The amount of nitrite plus nitrate was determined at the indicated
times in samples of the culture medium, after reduction of nitrate to nitrite, and using Griess reagent (A and C). NOS-2 protein levels were
determined at 24 h by Western blot using an antimurine-NOS-2 antibody (B). Activation of nuclear factor kB (NF-kB) was determined by
electrophoretic mobility shift assays using nuclear protein extracts from cells treated for 2 h with the indicated stimuli (D). Results show a
representative experiment (B and D) and the mean 6 SEM of three experiments. a, P , 0.05; *, P , 0.01 versus the none condition at the
indicated times (A) and the LPS condition (C), respectively.
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from the nucleus to the cytosol, and differential staining of the cells
with propidium iodide (PI) and SYTO 13 followed by microscopic
observation of the nuclei. Internucleosomal DNA fragmentation was
analyzed by agarose gel as follows: The cell layer (1 to 2 3 106 cells)
was washed twice with phosphate-buffered saline, and the plasma
membrane was lysed with 0.8 ml of 10 mM ethylenediaminetet-
raacetate (EDTA), 0.25% Triton X-100, 20 mM Tris-HCl (pH 8.0;
15 min at 4°C). The DNA from the total cell extract was precip-
itated with 70% ethanol plus 2 mM MgSO4 and treated for 4 h at
55°C with 0.5 mg/ml proteinase K. After two extractions with
phenol/chloroform, the DNA was analyzed in a 2% agarose gel and
stained with 0.5 mg/ml ethidium bromide (23,24). Alternatively,
the lysed cells were centrifuged at 30,000 3 g for 15 min to
remove nuclei and mitochondria and the DNA present in the
soluble fraction was analyzed using an enzyme-linked immunosor-
bent assay cell death kit (Boehringer) in which the histone-asso-
ciated DNA fragments were detected by a sandwich-enzyme im-
munoassay with antihistone and anti-DNA-peroxidase antibodies.
The relative degree of apoptosis was quantitatively determined by
measuring the peroxidase activity at 405 nm and calculating the
ratio between the enzyme activity of treated cells and the corre-
sponding value of control cells (enrichment factor). In addition to
these methods, the cells were stained in vivo with 0.005% of PI
(red fluorescence) and 50 mM SYTO 13 (green fluorescence;
Molecular Probes). The changes in cellular morphology and the
appearance of apoptotic bodies were determined by confocal
microscopy.
Preparation of Nuclear Extracts
Protein extracts were prepared following the method of Schreiber
et al. (25), as described previously. Protein content was assayed using
the Bio-Rad detergent-compatible protein reagent. All steps of cell
fractionation were carried out at 4°C.
Electrophoretic Mobility Shift Assays
The oligonucleotide sequences that correspond to the consensus
nuclear factor kB (NF-kB) binding site (nucleotides 2978 to 2952)
5'TGCTAGGGGGATTTTCCCTCTCTCTGT3' (26) of the murine
NOS-2 promoter were used. Aliquots of 100 ng of annealed oligonu-
cleotide were end-labeled with Klenow enzyme fragment. A total of
5 3 104 dpm of the DNA probe were used for each binding assay of
nuclear extracts as follows: 3 mg of protein were incubated for 15 min
at 4°C with the DNA and 2 mg of poly(dI:dC), 5% glycerol, 1 mM
EDTA, 100 mM KCl, 5 mM MgCl2, 1 mM dithiothreitol, and 10 mM
Tris-HCl (pH 7.8) in a final volume of 15 ml. The DNA-protein
complexes were separated on native 6% polyacrylamide gels in 0.5%
Tris-borate-EDTA buffer (27). Supershift assays were carried out
after incubation of the nuclear extract with the antibody (0.5 mg) for
1 h at 4°C, followed by electrophoretic mobility shift assays (EMSA).
Anti-p50 (human), anti-c-Rel (human), and anti-p65 (murine) anti-
bodies were from Santa Cruz Biotechnology.
Analysis of Mitochondrial Transmembrane Potential by
Confocal Microscopy
To measure the mitochondrial transmembrane potential (DVm),
cells were incubated at 37°C for 15 min in the presence of 30 nM
chloromethyl X-rosamine (CMXRos) (18), followed by immediate
analysis of fluorochrome incorporation in a confocal microscope. As
an internal control, labeled cells were incubated with 10 mM of the
uncoupling agent m-chlorophenylhydrazone carbonylcyanide (m-
ClCCP) that decreased CMXRos fluorescence (28,29). Cells were
visualized using an MRC-1024 confocal microscope (Bio-Rad), and
the fluorescence was acquired and electronically evaluated. Laser
sharp software (Bio-Rad) was used to determine the intensity of the
fluorescence per pixel. DVm was calculated as percentage of the
change in cell fluorescence versus the corresponding m-ClCCP con-
dition (100%).
Analysis of Mitochondrial Swelling
Mitochondria were prepared from renal cortex by differential cen-
trifugation in isolation medium (300 mM mannitol, 1 mM ethyleneg-
lycol-bis[b-aminoethyl ether]-N,N[prime]-tetraacetic acid, 10 mM
Tris-HCl [pH 7.4]; 1 mM PO4H2K, 0.5 mM phenylmethylsulfonyl
fluoride, 0.2% bovine serum albumin and gassed with N2) and resus-
pended 1:1 (vol:vol) in this medium. Mitochondrial swelling was
determined spectrophotometrically as described (28). The mitochon-
drial volume (ml/mg of protein) was calculated as [(1/A520 nm 2
0.119) 3 (protein)]/0.006. The assay was performed at 37°C under
continuous stirring.
Caspase Assay
The activity of caspases was determined in cell lysates using
N-acetyl-YVAD-7-amino-4-methylcoumarin (caspase 1) and
N-acetyl-DEVD-7-amino-4-methylcoumarin (caspases 3 and 7), re-
spectively, as fluorogenic substrates and following the instructions of
the supplier (PharMingen, San Diego, CA). The corresponding pep-
tide aldehyde and z-Val-Ala-DL-Asp-fluoromethylketone (z-VAD-
.fmk) were used to inhibit the caspase activity in vitro and in vivo,
Figure 2. Cyclosporine A (CsA) and FK506 inhibit NO synthesis in
proximal tubular epithelial cells (PTEC) stimulated with LPS or TPP.
Cells were incubated for 24 h with combinations of LPS (1 mg/ml; A)
or TPP (5 mg/ml; B), and CsA (10 nM), FK506 (10 nM), and 1400W
(100 mM). The synthesis of NO was determined by the accumulation
of nitrate plus nitrite. Results show the mean 6 SEM of three
experiments. *, P , 0.001 with respect to the LPS or TPP conditions;
a, P , 0.01 with respect to the none condition.
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respectively, and to ensure the specificity of the reaction. The linearity
of the caspase assay was determined over a 30-min reaction period.
Nitrite and Nitrate Determination
NO release to the culture medium was determined spectrophoto-
metrically by the accumulation of nitrite and nitrate as described (21).
Nitrate was reduced to nitrite and determined with Griess reagent by
adding sulfanilic acid and naphthylenediamine (1 mM in the assay).
The absorbance at 548 nm was compared with a standard of NaNO2.
Western Blot Analysis
The cell layers were washed twice with ice-cold phosphate-buff-
ered saline and scraped off the dishes, and the cells collected by
centrifugation. Cytosolic extracts were prepared after homogenization
with ice-cold 0.3 M sucrose, 1 mM EDTA, 0.5 mM phenylmethyl-
sulfonyl fluoride, 10 mg/ml leupeptin, and 20 mM Tris-HCl (pH 8.0)
and centrifugation for 10 min in an Eppendorf centrifuge. Aliquots of
10 mg of the soluble protein were submitted to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (10% gel) and transferred
to a polyvinylidene difluoride membrane (Amersham, Buks, UK). The
amount of NOS-2 was measured using a rabbit anti-mouse NOS-2
antibody (Santa Cruz Biotechnology) that recognized a protein of the
expected size (130 kD). The blot was revealed using the enhanced
chemiluminescence technique (Amersham).
Statistical Analyses
The data shown are the mean 6 SEM of four experiments. Statis-
tical significance was determined with t test for unpaired observations.
P , 0.05 was considered significant. In studies of Western blot
analysis, linear correlations between increasing amounts of input
protein and signal intensity were observed (correlation coefficients
.0.8).
Results
Bacterial Cell Wall Products and IL-1b Promote NOS-
2 Expression
Challenge of primary cultures of PTEC with LPS, the syn-
thetic lipopeptide derived from bacterial lipoproteins TPP and
IL-1b, promoted the expression of NOS-2 as assessed by the
time-dependent accumulation of nitrate plus nitrite in the cul-
ture medium (Figure 1A) and by the immunodetection of the
protein by Western blot (Figure 1B). The levels of NOS-2 in
cells treated for 24 h with LPS were 6- and 3.7-fold lower than
those elicited by TPP and IL-1b, respectively (Figure 1B).
Attempts to potentiate the effect of LPS with TNF-a, IL-1b,
and IFN-g (not shown) were ineffective, probably because
these cytokines, especially IFN-g, were not species specific
(see the “Discussion” section; Figure 1C). However, TPP in-
duced important levels of NOS-2 and synergized with IL-1b
(threefold increase in protein levels and enzyme activity at
24 h; Figure 1, B and C). Because NOS-2 expression requires
the activation of NF-kB, the sequence corresponding to the kB
site of the murine NOS-2 promoter was used in EMSA to
evaluate the engagement of this transcription factor in stimu-
lated PTEC. As Figure 1D shows, NF-kB was activated upon
treatment of the cells with LPS, TPP, IL-1b, and a high dose of
Figure 3. CsA and FK506 potentiate apoptosis induced by NO donors in PTEC. Cultured cells were treated for 24 h with the NO donors
3-morpholinosydnonimine (0.5 mM), 1-[2-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate] (1 mM), and S-nitrosogluta-
thione (GSNO; 0.5 mM) and with the immunosuppressors CsA (10 nM) and FK506 (10 nM). Apoptosis was determined following the laddering
of DNA in agarose gels (A) or determining the release of oligonucleosomal moieties from the nucleus to the cytosol using an enzyme-linked
immunosorbent sandwich assay that included anti-DNA and antihistone antibodies (B and C). *, P , 0.01 and **, P , 0.001 with respect to
the control condition.
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murine TNF-a. On analysis by supershift assays, the bands
retained corresponded mainly to p50-p65 (upper band) and to
p50-p50 dimers (lower band), respectively. It is interesting that
LPS increased the intensity of the upper band (p50-p65 com-
plexes) to levels similar to those elicited by TPP and IL-1b,
although the expression of NOS-2 was lower when compared
with the other bacterial stimuli TPP, suggesting the require-
ment of another cytokine, probably IFN-g, to accomplish
NOS-2 expression as described for other cells (26).
The NO synthesis induced by LPS and TPP decreased sig-
nificantly after treatment of the cells with 10 nM CsA and
FK506 (Figure 2). To ensure that this NO synthesis was due to
the expression of NOS-2, cells stimulated with LPS or TPP
were incubated with the NOS-2–specific inhibitor N-[3-(ami-
nomethyl)benzyl] acetamidine (1400W) and the amount of
nitrite plus nitrate was similar to that of untreated controls.
Neither of the immunosuppressors influenced NO production
in control cells. Concentrations of CsA higher than 100 nM
were toxic for these cells as deduced by the release of lactate
dehydrogenase to the extracellular medium after 24 h of culture
(not shown).
NO, CsA, and FK506 Induce Apoptosis in PTEC
NO has been recognized as a self-sufficient molecule induc-
ing apoptosis in various cell types (17,18,28). Indeed, treat-
ment of PTEC with NO donors such as 3-morpholinosydnoni-
mine, S-nitrosoglutathione (GSNO), and 1-[2-(2-aminoethyl)-
N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate] (NOC18)
induced apoptosis as determined by the appearance of a charac-
teristic DNA ladder (Figure 3A) and by the release of DNA
oligonucleosomal moieties from the nucleus to the cytosol (Figure
3B). CsA and FK506 also promoted apoptotic death of PTEC, an
effect that was potentiated in the presence of stimuli that induce
NOS-2 expression (TPP) or after release of elevated concentra-
tions of NO by NO donors (Figure 3B). The dose-dependent
effect of CsA and FK506 on apoptosis is shown in Figure 3C. The
half-maximal response was obtained at 20 nM and 15 nM of
FK506 and CsA, respectively. This ability of CsA and FK506 to
induce apoptosis in PTEC was evaluated also by confocal micros-
copy using PI and SYTO 13 simultaneous staining. As Figure 4
shows, CsA and FK506 induced the appearance of apoptotic
bodies and chromatin condensation in PTEC, a process that was
enhanced in the presence of the NO donor GSNO. A quantitative
determination of the cell population exhibiting apoptotic features
is shown in Table 1. Agreement was observed between the per-
centage of cells with apoptotic bodies (Table 1) and the relative
accumulation of oligonucleosomes in the cytosol (Figure 3, B and
C). Moreover, incubation of cells with the general caspase inhib-
itor z-VAD.fmk and with DEVD-CHO, that inhibits preferentially
the downstream caspases 3 and 7, prevented the apoptosis induced
by NO donors and immunosuppressors. The inhibition of apopto-
sis exerted by z-VAD.fmk persisted significantly up to 72 h after
treatment with GSNO and CsA (Table 1). Also, other inhibitors of
apoptosis, such as 3-aminobenzamide and 6(5H)phenanthridinone
(30,31), were very efficient in protecting the cells from apoptosis
(see the “Discussion” section). These data suggest that the apo-
ptosis induced in PTEC by NO donors and immunosuppressors
can be inhibited pharmacologically with these drugs.
A decrease of DVm has been described as a common, if not
causal, event in the induction of apoptosis in several cell types
Figure 4. Apoptosis of PTEC treated with GSNO and immunosuppressors. Cells were incubated for 24 h with 0.5 mM GSNO, 10 nM CsA,
10 nM FK506, or combinations of these. At the end of the incubation period, the cells were stained with propidium iodide (red fluorescence),
a dye excluded from viable cells that allows visualization of necrotic and early apoptotic cells, and SYTO 13 (green fluorescence), a live-cell
nucleic acid stain. Apoptosis was determined by morphologic changes and by the presence of condensed DNA and apoptotic bodies in SYTO
13 stained cells. The cells were visualized using confocal microscopy.
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(28,29). Incubation of PTEC with CMXRos as probe for the
determination of the DVm showed a decrease of potential after
prolonged treatment with GSNO and CsA (6 h). Simultaneous
addition of GSNO and CsA did not enhance the decrease of
DVm, suggesting the use of a common pathway in the irrevers-
ible opening of the permeability transition pore (PT; Figure
5A). As a positive control, we determined the changes of the
fluorescence produced by the uncoupling drug m-ClCCP,
which was considered as 100% of the decrease of DVm. These
results are compatible with a role for the fall of DVm in
CsA-dependent apoptosis. However, CsA has been character-
ized as an inhibitor of the PT in various cell types, at least at short
periods. Indeed, this was the case, and the pore remained un-
changed during the early 20 min after CsA treatment (Figure 5A),
a period during which no changes in volume of isolated mito-
chondria incubated with succinate were observed (Figure 5B). In
agreement with these data, mitochondrial swelling was observed
after 25 to 30 min of incubation with succinate and CsA.
Activation of Caspases in PTEC
The preceding results suggest a contribution of mitochon-
drial signals to induction of apoptosis in PTEC cells treated
Table 1. Inhibition of apoptosis by caspase inhibitorsa
Stimuli
Apoptotic Cells (per 100)
None z-VAD DEVD-CHO 6PTD ABZ
24 h
none 2 6 1 1 3 6 2 2 6 1 2 6 1
TPP, 5 mg/ml 16 6 1 8 6 1 10 6 1 3 6 1 2 6 1
IL-1b, 20 ng/ml 11 6 2 8 6 1 7 6 2 3 6 1 4 6 1
GSNO, 500 mM 19 6 2 7 6 1 9 6 1 3 6 1 5 6 1
CsA, 10 nM 14 6 2 7 6 2 6 6 1 4 6 1 3 6 2
TPP 1 IL-1b 24 6 3 11 6 2 11 6 2 5 6 1 5 6 1
TPP 1 CsA 30 6 3 10 6 1 11 6 2 6 6 1 6 6 1
GSNO 1 CsA 36 6 4 9 6 2 9 6 2 5 6 1 7 6 1
72 h
none 3 6 1 4 6 1
GSNO 25 6 3 12 6 3
CsA 32 6 4 17 6 2
GSNO 1 CsA 52 6 6 19 6 4
a PTEC were treated for 24 or 72 h with the indicated stimuli in the absence or presence of the caspase inhibitors z-VAD.fmk (50 mM)
and DEVD.CHO (100 mM) and with the immunosuppressors and apoptosis inhibitors 6PTD (0.5 mM) and ABZ (2 mM). The extent of
apoptosis was determined by confocal microscopy observation of apoptotic bodies after staining with PI and SYTO13, as described in
Figure 4. Results show the mean 6 SEM of three experiments (n 5 100 to 120 cells). PTEC, proximal tubular epithelial cells; 6PTD,
6(5H)phenanthridinone; ABZ, 3-aminobenzamide; TPP, tris-palmitoyl-peptide; IL-1b, interleukin 1b; GSNO, S-nitrosoglutathione; CsA,
cyclosporin A.
Figure 5. Effect of CsA and FK506 on DVm and mitochondrial swelling in PTEC. Cells were incubated with 0.5 mM GSNO, 10 nM CsA, and
10 nM FK506, and at the indicated times the DVm was measured after labeling the cells with 30 nM chloromethyl X-rosamine for 15 min at
37°C. The decrease of fluorescence of cells treated with m-chlorophenylhydrazone carbonylcyanide was considered as 100% of the change in
DVm (A). Isolated mitochondria from PTEC were incubated with 5 mM succinate and in the presence of 10 nM CsA or 10 nM FK506. The
swelling was determined spectrophotometrically (B). Results show the mean of five experiments.
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with NO donors and immunosuppressors. To determine the
involvement of caspases in this process, we measured the
activity of DEVD-specific caspase (3 and 7), which mediates
the executioner step of apoptosis, and caspase 1 (YVAD as
substrate), which is more related to inflammatory mechanisms.
As Figure 6 shows, DEVDase activity increased in cells that
were treated with GSNO and to a lower extent in cells that
were stimulated with CsA and FK506. Incubation of cells with
GSNO and CsA or FK506 did not increase significantly the
caspase activity induced by GSNO, suggesting the conver-
gence in the mechanisms of caspase activation. The activity of
caspase 1 remained unchanged regardless of the treatments
used, indicating that this activity was not involved in the
process.
Discussion
The expression of NOS-2 and the synthesis of NO by PTEC
may constitute an important event in the onset of inflammatory
renal diseases. PTEC exhibit a moderate response to LPS in
terms of expression of NOS-2 but are highly sensitive to the
action of proinflammatory cytokines and other components of
the bacterial cell wall, such as the lipoproteins (1,32). Our data
show that the apoptotic effects of NO are reinforced under
conditions of immunosuppression, suggesting a concerted
mechanism in the induction of apoptosis. This behavior of
PTEC regarding the sensitivity to NO and CsA/FK506-induced
apoptosis seems to be typical of these and other epithelial cells,
such as the cell lines LLC-PK1 and SH-SY5Y (30,33). Indeed,
protection against apoptosis and NOS-2 expression by CsA and
FK506 has been described in other cells, such as macrophages,
C6 glioma cell line, and L929 fibroblasts (21,34,35).
One advantage of the experimental model used was that the
cell cultures were virtually depleted of monocytes and acti-
vated T cells; therefore, the immunomodulatory molecules that
were produced after cell stimulation were synthesized mainly
by PTEC. This was confirmed by the absence in unstimulated
cells of NF-kB activity, a good sensor of inflammatory stress
(36,37). The mechanisms by which CsA and FK506 promote
apoptosis in PTEC are not clearly established, but mitochon-
drial swelling as a result of the fall of mitochondrial PT after
treatment with these drugs has been observed consistently.
Mitochondrial PT opening has been identified as a target of the
apoptotic action of NO both in intact cells and in reconstituted
systems that contain isolated mitochondria and nuclei
(18,28,29). Indeed, caspase 3 activity increased in cells that
were treated with GSNO, CsA, or FK506; however, absence of
synergic effects was observed when PTEC cells were incu-
bated with GSNO and CsA or FK506, suggesting the use of a
common downstream apoptotic pathway. Moreover, peptide
inhibitors of caspases such as zVAD-fmk and DEVD-CHO
(which inhibit caspase 3 and related caspases) prevented NO
and CsA/FK506-induced apoptosis in PTEC cells.
Several pathways have been proposed to explain the sensi-
tivity of PTEC to undergo apoptosis (6). These included en-
hancement of oxygen radical synthesis in the ischemia-reper-
fusion injury (38,39). Under these conditions, poly-ADP-
ribose polymerase (PARP) inhibitors proved to be effective in
protecting against apoptosis (40). In agreement with these
results, incubation of PTEC with PARP inhibitors 3-AB and
possibly 6(5H)phenanthridinone abrogated the apoptosis in-
duced by immunosuppressors and NO donors. The other can-
didate to mediate the toxic effects of NO and reactive oxygen
species is peroxynitrite. Indeed, in models of LPS-induced
kidney injury, an accumulation of nitrotyrosine has been de-
tected in PTEC, and it has been proposed that protein nitration
may participate in renal failure. The precise mechanism of
action of peroxynitrite in these cells is not fully understood
(38,41); however, it seems to involve an inhibition of the
adhesion properties of the PTEC, a process lost as a result of
NO and OONO synthesis (42). In this regard, removal of NO
and peroxynitrite with scavengers protected efficiently against
ischemia/reperfusion injury in the course of acute renal failure
(12,13).
Other indirect data suggest an important role for NO in the
degeneration of kidney functions, e.g., supplementation of the
diet with arginine increases renal injury (15). Moreover, in
transgenic sickle cell mouse kidney, there is an overproduction
of NO as a result of the massive expression of different forms
of NOS promoting apoptosis of PTEC and renal failure (38).
An enhanced NO synthesis together with the elevated accumu-
lation of oxygen superoxide leads to formation of peroxynitrite
and induction of apoptotic death of PTEC via tyrosine nitration
of proteins (38). These data point to mitochondrial apoptotic
signaling as one of the key factors that mediate the sensitivity
of renal cells to undergo apoptosis. In agreement with this
suggestion, mice that lack Bcl-2 develop polycystic kidneys
and exhibit rapid renal failure (4). In addition to the mitochon-
drial mediators, the coexistence of Fas signaling induced by
CsA and possibly by FK506 might explain the cooperative
induction of apoptosis by these two pathways (43).
The data reported show a selective capacity of PTEC to
Figure 6. DEVD-caspase activity increases after treatment of PTEC
with GSNO and immunosuppressors. Cells were treated for 18 h with
the indicated stimuli, and cell extracts were prepared to determine the
activity of caspases 3 and 7 (DEVDase activity) and caspase 1
(YVADse activity) using specific peptide substrate and inhibitors.
Results show the mean 6 SEM of four experiments. *, P , 0.01 with
respect to the control condition.
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express NOS-2. PTEC exhibit a slight response to LPS in terms
of NOS-2 expression, despite the intense activation of NF-kB
observed by EMSA. However, challenge with proinflamma-
tory stimuli, such as IL-1b, allows the synthesis of large
amounts of NO that are near the range of those elicited by
activated macrophages (under similar experimental conditions,
the steady-state levels of NO synthesis by activated RAW cells
and PTEC stimulated with lipid A plus IL-1b were 2 and 1.2
nmol of NO per hour and milligram of cell protein, respective-
ly). In addition to this source of NO, the possible contribution
of the infiltration of inflammatory cells such as macrophages
cannot be disregarded. These data should be considered in
other pathologies, such as multiorgan failure, in which treat-
ment with inhaled NO has been proposed (44).
In summary, our results show that PTEC exhibit a marked
sensitivity to apoptosis that involves the activation of DEVD-
specific caspases, a process that is initiated independently by
immunosuppressors and proinflammatory stimuli and that con-
stitutes a main cause of renal injury. Evaluation of strategies
that contribute to inhibition of NOS-2 expression (40), to
support mitochondrial function, e.g., the use of radical scav-
engers, or to inhibit downstream apoptotic events, e.g., PARP
inhibitors, might help to improve renal function under com-
promised situations, such as the immunosuppression that ac-
companies organ transplantation.
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